Qingdao NovelBeam Technology Co. Ltd. A (688677) - Total Assets
Based on the latest financial reports, Qingdao NovelBeam Technology Co. Ltd. A (688677) holds total assets worth CN¥1.51 Billion CNY (≈ $221.37 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Qingdao NovelBeam Technology Co. Ltd. A for net asset value and shareholders' equity analysis.
Qingdao NovelBeam Technology Co. Ltd. A - Total Assets Trend (2013–2024)
This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's total assets have evolved over time, based on quarterly financial data.
Qingdao NovelBeam Technology Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Qingdao NovelBeam Technology Co. Ltd. A's total assets of CN¥1.51 Billion consist of 58.3% current assets and 41.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 35.9% |
| Accounts Receivable | CN¥131.54 Million | 9.0% |
| Inventory | CN¥186.51 Million | 12.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥29.37 Million | 2.0% |
| Goodwill | CN¥3.61 Million | 0.3% |
Asset Composition Trend (2013–2024)
This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Qingdao NovelBeam Technology Co. Ltd. A.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Qingdao NovelBeam Technology Co. Ltd. A's current assets represent 58.3% of total assets in 2024, an increase from 40.1% in 2013.
- Cash Position: Cash and equivalents constituted 35.9% of total assets in 2024, up from 14.5% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 11.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 12.8% of total assets.
Qingdao NovelBeam Technology Co. Ltd. A Competitors by Total Assets
Key competitors of Qingdao NovelBeam Technology Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Hangzhou Alltest Biotech Co. Ltd. A
SHG:688606
|
China | CN¥4.11 Billion |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Qingdao NovelBeam Technology Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.75 | 11.98 | 2.62 |
| Quick Ratio | 3.62 | 9.47 | 1.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥702.35 Million | CN¥763.46 Million | CN¥103.91 Million |
Qingdao NovelBeam Technology Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Qingdao NovelBeam Technology Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.31 |
| Latest Market Cap to Assets Ratio | 1.68 |
| Asset Growth Rate (YoY) | 4.7% |
| Total Assets | CN¥1.46 Billion |
| Market Capitalization | $2.45 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Qingdao NovelBeam Technology Co. Ltd. A's assets above their book value (1.68x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Qingdao NovelBeam Technology Co. Ltd. A's assets grew by 4.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Qingdao NovelBeam Technology Co. Ltd. A (2013–2024)
The table below shows the annual total assets of Qingdao NovelBeam Technology Co. Ltd. A from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.46 Billion ≈ $213.66 Million |
+4.68% |
| 2023-12-31 | CN¥1.39 Billion ≈ $204.11 Million |
+0.09% |
| 2022-12-31 | CN¥1.39 Billion ≈ $203.92 Million |
+17.92% |
| 2021-12-31 | CN¥1.18 Billion ≈ $172.93 Million |
+183.19% |
| 2020-12-31 | CN¥417.31 Million ≈ $61.07 Million |
+26.53% |
| 2019-12-31 | CN¥329.82 Million ≈ $48.26 Million |
+20.86% |
| 2018-12-31 | CN¥272.90 Million ≈ $39.93 Million |
+18.21% |
| 2017-12-31 | CN¥230.86 Million ≈ $33.78 Million |
+9.30% |
| 2016-12-31 | CN¥211.21 Million ≈ $30.91 Million |
+12.71% |
| 2015-12-31 | CN¥187.39 Million ≈ $27.42 Million |
+13.34% |
| 2014-12-31 | CN¥165.34 Million ≈ $24.19 Million |
+13.58% |
| 2013-12-31 | CN¥145.56 Million ≈ $21.30 Million |
-- |
About Qingdao NovelBeam Technology Co. Ltd. A
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more